2001-2021
KEEP LIFE FLOWING

Learn moreKEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

WATCH THE INTERVIEW

In keeping with Kedrion’s continuing commitment to divulge precise medical-scientific information, Andrea Caricasole, Head of Research Innovation, tackles the topic of anti Covid treatment based on monoclonal and polyclonal antibodies.

NEWS

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

18-10-2021Kedrion grows in North America as it completes acquisition of PrometicLaunch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen DeficiencyRead all 14-10-2021Kedrion Biopharma expands its commitment in TurkeyExpansion plans revealed at Embassy reception in Ankara on October 14Read all 04-10-20214ID – Kedrion proud to support new App for patients with ImmunodeficienciesOur company restates its long-standing and consistent collaboration with IPOPIRead all
2020 Annual report Pharmacovigilance Medical Scientific Information VIDEO-GALLERY